Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques

[1]  H. Feldmann,et al.  Therapeutic strategies to target the Ebola virus life cycle , 2019, Nature Reviews Microbiology.

[2]  K. Karwowska,et al.  Ebola virus disease , 2019, The Lancet.

[3]  Timothy D. Flietstra,et al.  Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans , 2019, Emerging infectious diseases.

[4]  A. Marzi,et al.  Current Ebola Virus Vaccine Progress , 2019, BioDrugs.

[5]  N. Mackman,et al.  Measurement of tissue factor activity in extracellular vesicles from human plasma samples , 2018, Research and practice in thrombosis and haemostasis.

[6]  G. Palacios,et al.  A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever , 2018, Science Translational Medicine.

[7]  P. Jahrling,et al.  Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease , 2018, The American journal of pathology.

[8]  G. Palacios,et al.  Comparison of Transcriptomic Platforms for Analysis of Whole Blood from Ebola-Infected Cynomolgus Macaques , 2017, Scientific Reports.

[9]  J. Connor,et al.  Host Transcriptional Response to Ebola Virus Infection , 2017, Vaccines.

[10]  Saguna Verma,et al.  Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4 , 2017, Front. Microbiol..

[11]  Joshua C. Johnson,et al.  High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona , 2017, Scientific Reports.

[12]  J. Häberle,et al.  Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder , 2017, Expert opinion on therapeutic targets.

[13]  Daniel S. Chertow,et al.  The Pathogenesis of Ebola Virus Disease. , 2017, Annual review of pathology.

[14]  John G Kenny,et al.  Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus , 2017, Genome Biology.

[15]  F. Hayden,et al.  Experimental Therapies for Ebola Virus Disease: What Have We Learned? , 2017, The Journal of infectious diseases.

[16]  Pardis C Sabeti,et al.  In vivo Ebola virus infection leads to a strong innate response in circulating immune cells , 2016, BMC Genomics.

[17]  T. Lämmermann,et al.  Neutrophil swarming: an essential process of the neutrophil tissue response , 2016, Immunological reviews.

[18]  A. Goff,et al.  The Role of Cytokines and Chemokines in Filovirus Infection , 2015, Viruses.

[19]  M. Netea,et al.  Ebola Virus Disease has Features of Hemophagocytic Lymphohistiocytosis Syndrome , 2015, Front. Med..

[20]  P. Rollin,et al.  Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses , 2015, The Journal of pathology.

[21]  Joshua C. Johnson,et al.  Ebola Virus Exploits a Monocyte Differentiation Program To Promote Its Entry , 2013, Journal of Virology.

[22]  Atsushi Okumura,et al.  Interaction between Ebola Virus Glycoprotein and Host Toll-Like Receptor 4 Leads to Induction of Proinflammatory Cytokines and SOCS1 , 2009, Journal of Virology.

[23]  C. Basler,et al.  Evasion of interferon responses by Ebola and Marburg viruses. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[24]  H. Feldmann,et al.  The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. , 2009, Virus research.

[25]  P. Rollin,et al.  Cytokine and chemokine expression in humans infected with Sudan Ebola virus. , 2007, The Journal of infectious diseases.

[26]  G. Ruthel,et al.  Activation of Triggering Receptor Expressed on Myeloid Cells-1 on Human Neutrophils by Marburg and Ebola Viruses , 2006, Journal of Virology.

[27]  P. Jahrling,et al.  Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. , 2003, The Journal of infectious diseases.

[28]  P. Jahrling,et al.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.

[29]  G. Olinger,et al.  Nonhuman Primate Models of Ebola Virus Disease. , 2017, Current topics in microbiology and immunology.

[30]  J. Crawford,et al.  The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1 , 2008, Laboratory Investigation.

[31]  C. Goldsmith,et al.  Pathologic features of filovirus infections in humans. , 1999, Current topics in microbiology and immunology.